When more free radicals than antioxidants are present, oxidative cell damage occurs
This growth is largely attributed to the rising prevalence of chronic disease conditions and the associated demand for vaccines, biologics, and precision medicine, the market for which is estimated to reach USD 157.1 billion by 2032
Although promising, these applications are still under study, and they should only be used as prescribed by a healthcare professional
In adults with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and stage 2 or 3 fibrosis, semaglutide 2.4 mg achieved MASH resolution without fibrosis worsening in 62.9% of treated patients versus 34.3% on placebo at 72 weeks
The activity-dependent nature of BDNF expression is worth understanding
From the perspective of the clinical care of T2D patients who require intensified injection therapy, our findings are consistent with existing treatment guidelines [1, 3] and a real-world study [47], showing that using a GLP-1RA versus insulin therapy has therapeutic benefits in terms of reduced risks of hypoglycemia and all-cause death